Hormone-Sensitive Prostate Cancer Responds to Early PARP Blockade – Inside Precision Medicine

  1. Hormone-Sensitive Prostate Cancer Responds to Early PARP Blockade  Inside Precision Medicine
  2. ‘Striking’ new treatment for deadly prostate cancer could increase life expectancy  The Independent
  3. Published data show benefit of niraparib with AAP…

Continue Reading